3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
40
Burkitt Lymphoma
9
Precursor Cell Lymphoblastic Leukemia-Lymphoma
7
Recurrence
5
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
4
Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Rectal Neoplasms
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Ovarian Neoplasms
2
Neoplasms, Plasma Cell
2
Lymphoma, Mantle-Cell
2
Lung Neoplasms
2
Leukemia
2
Down Syndrome
2
beta-Thalassemia
1
Waldenstrom Macroglobulinemia
1
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Thalassemia
1
Smoldering Multiple Myeloma
1
Prostatic Neoplasms, Castration-Resistant
1
Prostatic Neoplasms
1
Plasmacytoma
1
Plasmablastic Lymphoma
1
Oropharyngeal Neoplasms
1
Neoplasm Metastasis
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Interventions
X-Rays
5
Phantoms, Imaging
5
Nuclear Medicine Department, Hospital
5
Magnetic Resonance Spectroscopy
5
Specimen Handling
4
Biopsy
4
ulixertinib
2
tipifarnib
2
selpercatinib
2
olaparib
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
ensartinib
2
tazemetostat
1
palbociclib
1
lutetium Lu 177 dotatate
1
Vemurafenib
1
Temozolomide
1
Pharmacogenomic Variants
1
Nivolumab
1
Linear Energy Transfer
1
LY3023414
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Ependymoma
×
Dexamethasone
×
30 days
×
Clear all
No trials found.